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Abstract 
 The Type V auto-secreting proteins of Gram-negative bacterial pathogens have been 
shown to be important surface-expressed molecules that facilitate colonization and in vivo 
survival.  In particular, Brucella species have been shown to carry genes with the potential to 
express several Type V and Type V-like secreted proteins that are antigenic, possess putative 
virulence function, and may very well contribute to persistence of the microorganism in 
susceptible hosts (cattle, pigs, bison, sheep, and cervids [elk and deer]). Additionally, some of 
these proteins may be differentially surface-expressed and thus potentially represent species-
specific markers. Experiments were therefore conducted to assess the feasibility of selected 
recombinant outer membrane proteins to be used to distinguish between B. abortus, B. 
melitensis, B. suis, and B. ovis infection in various host species. A total of four Brucella genes 
were previously cloned in E. coli and their recombinant products expressed and purified by 
established molecular procedures.  Methods for determining sero-reactivity of these potential 
diagnostic targets consisted of SDS-PAGE, electroblotting, and immunolabelling with anti-sera 
from goats, sheep, cattle, and elk infected with either of the three pathogenic Brucella spp.  
Quantitative analysis of protein gels and Western blots was conducted by digital imaging.  
Results of this study reinforce the practicality of one or a number of these bacterial envelope 
proteins for use in a rapid serologic-based field assay for Brucellosis in wild and domestic 
animal hosts. Furthermore, these antigens may have utility in a test that can differentiate 
infection by pathogenic Brucella species specific to a target host. 
 
Objective 
 The objective of this study was to evaluate the feasibility of using novel recombinant 
outer membrane proteins from three Brucella species as species-specific indicators of Brucella 
infection in a rapid solid-phase diagnostic assay. 
 
Introduction 
 Brucellosis is an economically relevant cause of livestock and wildlife abortions 
worldwide, and the primary etiology of brucellosis, the facultative intracellular bacteria Brucella 
abortus, can be transmitted to humans, especially those who work closely with susceptible 
animal hosts1. The primary host of B. abortus is cattle, but it also infects wildlife, especially 
cervids such as elk and deer. These reservoirs make eradicated of the pathogen in livestock, 
especially in the Greater Yellowstone Region, significantly challenging. Two additional zoonotic 
species examined in this study, B. melitensis and B. suis, infect mainly goats, sheep, and pigs and 
are also causes of economic losses in livestock2. Diagnosing brucellosis pre-abortion and 
controlling its spread presents challenges because animal hosts are often asymptomatic prior to 
spontaneous fetal abortion, and domestic animals are often susceptible to contact with wildlife 
reservoirs. A reliable and rapid diagnostic assay for Brucella infection has the potential to 
contribute significantly to disease management within livestock throughout Wyoming and the 
world1. Currently, diagnostic methods for brucellosis are limited by a lack of reliable antigenic 
targets that exhibit high sensitivity and specificity to Brucella infection. Serologic diagnostic 
strategies used now are based on reactivity to lipopolysaccharide (LPS), but these tests tend to 
produce a high number of false positives because many animals are chronically infected with 
Gram-negative bacterial commensals and pathogens3 that possess cross-reactive LPS. 
 Surface-expressed Type-V auto-secreting proteins are promising candidates for 
producing an accurate and precise diagnostic assay because they are highly antigenic and may 
likely more consistently stimulate the humoral immune response of the host upon infection1. 
Recent genomic analysis has suggested autotransporter proteins of Type-V secretion systems are 
the largest family of secreted proteins in Gram-negative bacteria such as Brucella, but relatively 
few have been characterized. Some members of this family have already been shown to act as 
important virulence factors in several Gram-negative pathogens, and it is likely that future 
research will reveal many are essential for the pathogenesis of numerous virulent bacterial 
species, to include Brucella10. Previous research in Dr. Andrews’ lab identified several B. 
abortus antigenic targets with potential for use in a serologic-based assay. Sero-reactivity tests 
against the proteins of interest concluded that one in particular, Hia, gave relatively high 
sensitivity and specificity in a single-antigen lateral flow platform and was thus selected for 
further study as a potential diagnostic target.  
 Evaluation of the physical properties of Hia has been done in order to better understand 
the conformation of the protein under physiologic conditions. Hia was found to exist primarily as  
dimeric and trimeric complexes of a 76 kDa monomer4. A single-antigen (Hia) lateral flow 
device was tested in the lab against ELISA-confirmed positive and negative samples of infected 
sera. The lateral flow device had a sensitivity of 100% and a specificity of 86.7% to elk sera but 
exhibited a significantly lower sensitivity to cattle sera (47.6%) 5. This difference in predictive 
value between host species may be due to differential expression of Hia by B. abortus within the 
course of infection. Reduced sensitivity could also be due to differences in the immune response 
by the host. Regardless, a test with an increased predictive value of Brucella infection within the 
cattle host is needed. 
In an effort to optimize the lateral flow device to detect Brucella infection in cattle and to 
potentially differentiate between B. abortus, B. melitensis, B. suis and B. ovis infection, the 
feasibility of two additional surface-expressed T-V proteins in Brucella, BruAb1_0720 and 
BruAb1_1988, were evaluated for use1._0720 is predicted to be a 25 kDa surface-expressed 
protein of Type-V homology. The protein has an evolutionarily conserved domain and possesses 
homology to virulence factors in enterotoxigenic E. coli (ETEC)  and Shigella flexneri. Its exact 
function is unknown, but because it exists in allelic copies within the genome, it may be 
differentially expressed with varying antigenic properties on the surface of the microorganism. 
We intend to test the sero-reactivity of _0720 against control sera to assess its sensitivity and 
specificity to infection in various host species. 
 _1988 is a high molecular weight (92 kDa) hydrophilic Type-V protein present in B. 
melitensis, and B. suis species, but, according to genome sequencing in the NCBI database, is 
present as a pseudogene in B. abortus. The coding sequence of _1988 in B. abortus is interrupted 
by two point mutations that introduced stop codons into the open reading frame. Because of the 
presumable absence of its expression in B. abortus, this protein may therefore be useful as a 
diagnostic marker capable of differentiating between infection by B. abortus and infection by B. 
melitensis or B. suis1.  
 A previous researcher in Dr. Andrews’ lab successfully expressed and isolated both the 
_1988 N-terminal and C-terminal domains as separate polypeptides (_1988 and _1988C, 
respectively).  The C-terminus (_1988C) is predicted to be the “translocator” of the  “passenger” 
domain (_1988), which is the functional moiety of the protein6. Its expression in B. abortus is 
unknown. We will test for sero-reactivity against the protein to further characterize its presence 
and potential role in virulence in B. abortus and to evaluate its role as a differential diagnostic. 
We also intend to complete further tests for sero-reactivity to Hia for comparison against the 




Control sera used in the experiment was obtained from the American Type Culture 
Collection (ATCC) and the National Veterinary Services Laboratories (NVSL). Each sera 
sample was confirmed positive or negative for infection using the combined results of several 
reliable serologic techniques. The method of sera preparation for both the ATCC and NVSL 
samples is unknown. 
 
1. SDS PAGE 
 Hia, _0720, _1988, and _1998C proteins were mixed with equal volumes of tris-glycine- 
SDS buffer (+ 5% beta-2-mecaptoethanol) in Eppendorf tubes, and denatured in an 85-90°C 
water bath for 10 minutes prior to loading on preparative polyacrylamide gels (Novex 4-20% 
tris-glycine, single well). All gels were ran at approximately 120 volts and 20 mA until the dye 
front was 1 cm from the bottom of the gel. 
2. Electroblotting 
 Following SDS PAGE, each protein was transferred onto a pure nitrocellulose blotting 
membrane with a pore size of 0.45 micrometers. Three sheets of blotting paper soaked in 
electroblotting buffer (see solution formulation 2.1) were stacked on a cathode, then the gel 
placed on top followed by the nitrocellulose paper and three additional sheets of soaked blotting 
paper. The nitrocellulose was cut to size to fit the gel. The protein was transferred at 0.2 amps 
constant current for 1 hour. The blot was allowed to dry overnight, then scored into 
approximately 0.5 mm wide strips. This procedure was repeated for all proteins for a total 
protein concentration of approximately 200 nanograms per strip. 
3. Immunolabelling 
 To assess the sero-reactivity of the recombinant proteins, 4 trials of immunolabelling 
were completed, each with different sets of sera samples examined. All trials were carried out 
using the following procedure. Eight-lane slot blots were filled with strips of electroblotted 
nitrocellulose, one tray for each protein. Each strip was scored on the bottom right corner to 
indicate which side was imprinted with protein. One ml of Blotto blocking solution (see solution 
formulation 3.1) was added to each lane. All trays were placed on a rocker and gently rocked for 
30-90 minutes. The blocking solution was removed, and 1 ml of each antibody was added in 
quadruplicate to each of the four trays (lane designations for the first 3 trials are indicated in 
Tables 1-3 below). In the fourth trial, 2 trays of the _1988 protein were prepared for a total of 5 
total trays in that trail (lane designations are indicated in Tables 4 and 5 below). In the first and 
third trials, each serum sample was diluted in a 1:200 ratio of antibody to Blotto.  In the second, 
ATCC anti-B. abortus, B. melitensis, and B. suis sera were diluted 1:50 in Blotto. The trays were 
rocked for 90 minutes and washed 4x with PBS/Tween-20 washing buffer (see solution 
formulation 3.2). A 10-minute rocking period per wash was included in the last 3 washing 
cycles. One ml of Protein-G conjugate (see solution formulations 3.3) in a 1:2000 dilution was 
then added to each lane and allowed to incubate on the rocker for 2 hours. The trays were then 
washed 7 more times with PBS/Tween-20 with a 5-minute rocking period per wash for the last 6 
washes. One ml of alkaline phosphatase conjugated Protein-G was then added to each lane, and 
all trays were rocked until bands were visible. Following visual confirmation of the presence of 
bands, the trays were washed with tap water to stop the reaction from producing excessive 
background. Sero-reactivity for each sample was recorded. Faint and strong positive samples 
were noted. 
Table 1. Lane designations for immunolabelling, trial #1. 
Lane Antibody Serum 
1 Alk. Phos.-conj. Protein G (control) 
2 ATCC B. suis 
3 ATCC B. melitensis 
4 ATCC B. abortus 
5 NVSL sheep, B. ovis (+) 
6 NVSL sheep, B. ovis (-) 
7 NVSL cattle, B. abortus (+) 
8 NVSL cattle, B. abortus (-) 
 
Table 2. Lane designations for immunolabelling, trial #2. 
Lane Antibody Serum 
1 NVSL sheep, B. ovis (-) 
2 ATCC B. abortus 
3 ATCC B. melitensis 
4 ATCC B. suis 
5 Elk, B. abortus (+), sample #300 
6 Elk, B. abortus (+), sample #301 
7 NVSL cattle, B. abortus (+) 
8 NVSL cattle, B. abortus (-) 
 
Table 3. Lane designations for immunolabelling, trial #3. 
Lane Cattle Anti-serum (NVSL proficiency test reagent) 
1 Serial #512-0350, sample #1 - negative 
2 Serial #512-0350, sample #4 - positive 
3 Serial #512-0350, sample #7 - positive 
4 Serial #512-0350, sample #10 - positive 
5 Serial #512-0350, sample #16 - negative 
6 Serial #512-0347, sample #4 - positive 
7 Serial #512-0828, sample #14 - negative 
8 Serial #512-0828, sample #16 - negative 
 
Table 4. Lane designations for immunoblotting, trial #4. 
Lane Elk Anti-serum 
1 B. abortus  “POS” (+), sample #33 
2 B. abortus (+), sample #38 
3 B. abortus (+), sample #58 
4 B. abortus (+), sample #72 
5 B. abortus “NEG” (-), sample #43 
6 B. abortus (-), sample #44 
7 B. abortus (-), sample #53 
8 B. abortus (-), sample #63 
 
Table 5. Lane designations for immunoblotting, trial #4. _1988 sero-reactivity against B. abortus 
(+) and immunized (S19+) elk. 
Lane Elk Anti-serum 
1 B. abortus (+), sample #18 
2 B. abortus (+), sample #36 
3 B. abortus (+), sample #60 
4 B. abortus (+), sample #68 
5 B. abortus S19 vaccine strain (+) elk, sample J13 
6 B. abortus S19 (+) elk, sample J19 
7 B. abortus S19 (+) elk, sample J20 
8 B. abortus S19 (+) elk, sample J21 
 
Solution Formulations 
2.1 Electroblotting Buffer. 200 ml of laboratory grade methanol, 5.82 g tris base, 2.93 g glycine, 
and 0.375 g SDS were mixed on a stir plate. Deionized water was added to fill to 1 L. The 
solution was stored on the bench at room temperature. 
3.1 Blotto. 500 mL of 10X PBS, 25 g of 5% nonfat dry milk, and 1 ml of Tween-20 were 
combined on a stir plate and mixed to homogenization. The solution was stored in the 
refrigerator. 
3.2 Washing Buffer. 2 L of 1X PBS and 4 ml of tween 20 were combined on a stir plate. The 
solution was stored on the bench at room temperature. 
3.3 Protein-G, Alkaline Phosphatase-conjugated.  Protein-G is a surface protein of two groups of 
Streptococcal bacteria that binds to the fragment crystallizable portion of immunoglobulins.  
4. Molecular Weight Identification 
 The molecular weights of the four proteins of interest were identified by comparing their 
band location to a molecular weight standard (bovine serum albumin) of known concentration on 
the SDS PAGE. 
 
Results 
Molecular Weight Identification 
 The Hia monomer had a molecular weight of 65 kDa, which is less than the predicted 
value of 76 kDa. The _1988 protein had a molecular weight of about 75 kDa (see Figure 1.). The 
predicted molecular weight of _1988 is 92 kDa. The molecular weights of both Hia and the 
_1988 proteins were likely less than the predicted values because the proteins used in this 
experiment were not complete proteins. _0720 had a molecular weight of 35 kDa, which is 
greater than the predicted weight of 24 kDa (see Figure 2.). This difference was due to the 
presence of additional linker amino acid residues amounting to 7.5-10 kDa in weight. The 
molecular weight of _1988C was not previously characterized and was found to be about 70 kDa 
(see Figure 3). 









*MWM = molecular weight marker (kDa). 
 



















Figure 2. Gel electrophoresis of purified         Figure 3. Gel electrophoresis of purified   











Table 6. Reactivity of tested sera against four potentially diagnostic outer membrane proteins. 
Sera Hia _720 _1998 _1988C 
Alk. Phos.-conj. Protein G (control)     
ATCC B. abortus, trial #1     
ATCC B. abortus, trial #2     
ATCC B. melitensis, trial #1     
ATCC B. melitensis, trial #2     
ATCC B. suis, trial #1     
ATCC B. suis, trial #2     
NVSL sheep, B. ovis (+)     
NVSL sheep, B. ovis (-)     
NVSL sheep, B. ovis (-)     
Elk, B. abortus (+), sample #300     
MWM*         720  720  720      


















































     MWM* 1988C  
Elk, B. abortus (+), sample #301     
Elk, B. abortus (+), sample #33     
Elk, B. abortus (+), sample #38     
Elk, B. abortus (+), sample #58     
Elk, B. abortus (+), sample #72     
Elk, B. abortus (-), sample #43     
Elk, B. abortus (-), sample #44     
Elk, B. abortus (-), sample #53     
Elk, B. abortus (-), sample #63     
NVSL cattle, B. abortus (+)     
NVSL cattle, B. abortus (+)     
NVSL cattle, B. abortus (+)     
NVSL cattle, B. abortus (+)     
NVSL cattle, B. abortus (+)     
NVSL cattle, B. abortus (+)     
NVSL cattle, B. abortus (-)     
NVSL cattle, B. abortus (-)     
NVSL cattle, B. abortus (-)     
NVSL cattle, B. abortus (-)     
NVSL cattle, B. abortus (-)     
NVSL cattle, B. abortus (-)     
 
Dark grey boxes indicate a strong positive, medium grey a faint positive, and white boxes a 
negative reaction. 
Table 7. Sero-reactivity against _1988 in B. abortus (+) and immunized (S19+) elk. 
Sera _1988 
Elk, B. abortus (+), sample #18  
Elk, B. abortus (+), sample #36  
Elk, B. abortus (+), sample #60  
Elk, B. abortus (+), sample #68  
B. abortus S19 (+) elk, sample J13  
B. abortus S19 (+) elk, sample J19  
B. abortus S19 (+) elk, sample J20  
B. abortus S19 (+) elk, sample J21  
 
Examples of positive and negative bands for each antigen are indicated in the figures 4-7. 
    
    
Figure 5. 720 (+)/(-)  
          Figure 7. 1988C (+)/(-) 
             Figure 6. 1988 (+)/(-)  
Figure 4. Hia (+)/(-) 
 
 The protein G control showed no bands and therefore indicated a proper test. Both ATCC 
B. abortus and ATCC B. melitensis serum showed no reactivity to any of the proteins. ATCC B. 
suis serum showed reactivity to the Hia monomer,  _0720, and _1988 in the first trial, and 
reactivity to only _0720 and _1988 in the second. The B. ovis positive sheep sample showed 
reactivity to Hia monomers and multimers, _0720, _1988, and _1988C. A second trial of the B. 
ovis negative sheep blot strips were ran because of an excess of non-specific binding in the first 
trial. The second trial showed no non-specific binding and negative reactivity to all the proteins.  
 Ten elk sera samples were next evaluated for reactivity against all four proteins, six 
positive and four negative, and eight additional positive samples were evaluated against _1988 
alone. Half of the samples tested against _1988 were from naturally infected animals, and half 
were experimentally immunized with S19 B. abortus. Of the six positive elk samples, four were 
reactive against the Hia monomer. Five of six positive samples were reactive against _1988, and 
three of six against _1988C. The negative elk samples were not reactive. Of the sera samples 
tested against _1988 only, three of the four naturally infected positive elk sera were reactive, and 
three of the four immunized elk sera were positive. 
 Twelve total cattle samples of were ran against each of the four proteins, six positive for 
infection and six negative. Of the six positive samples, one showed strong reactivity to the Hia 
monomer and two showed moderate reactivity. Two of the six negative samples also showed 
strong reactivity to the Hia monomer. None of the cattle samples showed reactivity to Hia 
multimers. Only one positive sample showed reactivity to _0720, and the level of reactivity was 
moderate. Four positive samples showed some level of reactivity to both _1988 and _1988C, five 




 The sero-reactivity results of the ATCC anti-B. abortus goat serum were unexpected. No 
reactivity was seen against any protein, even though B. abortus RB51 is known to constitutively 
express Hia in vitro based on mRNA analysis (Andrews, unpublished data). Hia has even been 
shown to reduce bacterial loads when used as a vaccination in mice and is therefore known to be 
immuno-stimulatory, so the absence of its expression was surprising7. We did not expect to see 
reactivity against _1988 because B. abortus likely does not express a complete _1988 protein, 
but it is unknown whether or not B. abortus expresses the C-terminal end of the protein. 
Reactivity against _1988C would have suggested that B. abortus expresses a truncated version of 
_1988, but no such reactivity was observed. The ATCC B. meltensis serum also showed no 
reactivity against any of the proteins and therefore provided no indication of the use of Hia, 
_0720, or _1988 to delineate between B. abortus and B. melitensis infection. The ATCC B. suis 
serum showed consistently strong reactivity to _0720, suggesting that antibody to this protein 
could be indicative of B. suis infection.  
 The sero-reactivity of B. abortus and B. melitensis would be better evaluated using sera 
from naturally infected hosts. The ATCC sera samples we used came from goats, and we do not 
know how either pathogen behaves within this host environment. It is also unclear as to how the 
ATCC anti-goat sera were prepared.  They may have been made using heat-killed Brucella as the 
immunogen, in which proteins expressed specifically in-vivo within the course of infection 
would not have been present. 
 Surprisingly, B. ovis anti-serum from confirmed POS animals was strongly reactive to all 
four proteins. We had no prior knowledge of how Hia, _0720, or _1988 is expressed by B. ovis, 
but our results clearly suggest these antigens could have potential for use as diagnostic markers 
of B. ovis infection. Furthermore, _0720 may represent a novel protein marker of B. ovis 
infection.  A more thorough evaluation of the feasibility of the use of these proteins to detect B. 
ovis infection in sheep is planned for future study.  
 The results we obtained from the elk sera confirmed previous research that suggested Hia 
is a signature of B. abortus infection within the elk host. Prior to this study, _1988 had not been 
evaluated in either naturally infected or immunized elk hosts. Interestingly, our results showed 
moderate to strong reactivity to _1988 in both animals, which we previously hypothesized was 
not an intact protein in B. abortus. These results could be due to the cross-reactivity of other 
outer membrane proteins from non-B. abortus commensal or pathogenic bacterial species within 
the elk sera, or, alternatively, the B. abortus strain infecting these elk may in fact express an 
intact _1988 protein. Other investigators have sequenced a B. abortus strain endogenous to 
Korea that exhibits an intact _1988 coding sequence for the protein8, so it is possible that 
uncharacterized B. abortus strains within the wildlife reservoir of the Greater Yellowstone 
Region have maintained an intact _1988 open reading frame within their genome. Alternatively, 
these strains may have reverted through secondary mutation to ablate one or both nonsense 
codons. It is also possible that the elk are chronically infected with the vaccine strain 19 (S19) of 
B. abortus. According to the NCBI database, the gene sequence of the _1988 protein in S19 is 
most likely intact, meaning S19 infection in the elk could be the source of reactivity. We also 
observed sero-reactivity of _1988 within S19-infected animals, further validating this hypothesis. 
With additional evaluation, _1988 could prove to be a reliable (but perhaps, not a unique marker) 
for Brucella infection within the elk host. 
 The Hia sero-reactivity results we obtained using the cattle sera were somewhat as 
expected, as the sensitivity of Hia in a lateral flow platform for diagnosis of B. abortus infection 
in cattle is only 48% (half of that observed with elk)5, but no other protein tested was observed to 
be a reliable potential diagnostic marker. _0720 showed very little reactivity (faint reactivity in 
one of six positive sera samples), and _1988 and _1988C showed strong and moderate reactivity 
in both infected and uninfected animals. These results were surprising. We suspect the sera 
samples could have came from RB51 vaccine-exposed cattle, causing reactivity to _1988 and 
_1988C in the negative cattle samples9. Also, B. abortus 2308, the vaccine strain, could express a 
complete _1988 protein or a similar Type-V protein that was cross-reactive with our samples. 
Once again, the nature of the sera obtained from the National Veterinary Services Laboratories in 
unknown and cannot be determined. To improve the efficacy of this study, _1988 should be re-
evaluated in cattle using sera from confirmed naturally infected and un-immunized individuals. 
Although the results we obtained do not support the identification of a reliable and novel 
outer membrane protein diagnostic marker for B. abortus infection in cattle, our results regarding 
B. ovis-infected sheep are compelling and warrant further research. We have also identified 
several potential sources of cross-reactivity that may indicate false positives when outer 
membrane proteins are used as diagnostic markers. We intend to further evaluate the potential 
for pathogen-specific outer membrane proteins to act as diagnostic markers and will look for new 
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